Agitation and aggression in dementia — it's the disease, not the person

Reviewed by the How To Help Your Elders medical review team

Clinical trials offer access to experimental treatments before they reach the market, but they are research studies, not guaranteed therapy. Most dementia trials produce modest results at best, and your parent could receive a placebo, experience side effects, or gain no benefit at all. Understanding the realistic odds and your parent's own wishes is the foundation of a sound decision.

The Honest Answer: Most Trials Do Not Produce Breakthroughs

Your parent's doctor mentions a clinical trial, and you feel a pull toward it immediately. This is something active, something that fights back against the diagnosis instead of just watching decline happen. That pull is real, and it matters.

But you need to know what you are signing up for. Clinical trials are research studies designed to test whether a new medication or treatment works and whether it is safe. They are not treatment plans. Before a medication can be approved by the FDA, it goes through years of testing in laboratories, in animals, and then in human participants through clinical trials. Researchers design a trial to answer specific questions. They find willing participants, randomly assign them to receive either the new treatment or a control condition (often a placebo), follow them over time, and analyze the data.

For your parent, participating means being part of this research process. It means taking a medication that has not been fully proven to work. It means following a trial protocol with specific rules about dosing, visits, tests, and monitoring. It means being willing to receive either the treatment or a placebo.

According to the Alzheimer's Association, more than 140 therapies are currently in clinical trials for Alzheimer's disease alone. The NIH reports that the failure rate for Alzheimer's drug candidates exceeds 99 percent. The few newer medications for early Alzheimer's that have been approved based on clinical trial data show they slow cognitive decline by a modest amount. We are talking about a few months of delay in progression, not a reversal. That is the level of benefit being seen right now.

In trials for later-stage disease or for other neurodegenerative conditions, results are even more modest or nonexistent. Many trials are negative, meaning the medication did not help. Your parent spent months following protocols, coming to appointments, getting blood drawn, and potentially experiencing side effects, and the data shows the medication did nothing for them. That is valuable for science. It is not helpful for your parent.

Some trials are double-blind, meaning neither the researchers nor your parent knows whether they are getting the real medication or a placebo. Others are open-label, meaning everyone knows they are getting the real thing. Your parent could spend months taking a pill without knowing if it is the actual treatment or sugar.

Side effects are a real possibility. Amyloid-targeting monoclonal antibodies, for example, can cause amyloid-related imaging abnormalities (ARIA), including brain microhemorrhages and brain edema. These are monitored carefully with MRI scans, but they are genuine risks. Your parent could experience side effects without getting any benefit. This happens.

What to Think Through Before Saying Yes

If your parent's doctor thinks they are a good candidate, there are specific questions worth working through before making a decision.

Eligibility comes first. Trials have strict inclusion and exclusion criteria. Your parent might meet the diagnosis requirements but be ruled out because of age, other medical conditions, or medications they take. The trial team determines eligibility, and their decision is final.

Time commitment matters more than people expect. Some trials require monthly visits. Some require visits every two weeks. Some visits last a few hours. If your parent has transportation challenges or lives far from the research center, the burden adds up fast.

Ask the researchers what side effects have been seen in earlier studies. Ask what monitoring will be done to catch problems early. Ask what happens if your parent has a serious side effect and whether their insurance covers complications.

Understand the chance of getting the real medication versus a placebo. In many randomized trials, the odds are 50/50. If the placebo chance is high and the trial is risky, think carefully about whether it makes sense.

Ask about the actual evidence that this treatment might work. Some trials are based on very early laboratory data. Others are based on promising results from earlier human trials. The stronger the evidence base, the more reasonable it is to hope for benefit.

Where your parent is in their disease trajectory matters. Trials for early Alzheimer's are different from trials for moderate to advanced Alzheimer's. Early-stage trials have more room to slow progression. Late-stage trials are less likely to show benefit because so much function is already lost.

Ask what happens at the end of the trial. Will your parent get to continue the medication if it helps? Some trials offer this. Some do not. Some trials end and your parent goes back to no disease-modifying treatment.

Your parent's own preference matters most. Some people with cognitive decline want to contribute to science and want to try something new. Some do not. Ideally, this decision should be made while your parent is cognitively intact enough to truly understand the trial and make the choice themselves.

How to Find Trials

ClinicalTrials.gov, maintained by the U.S. National Library of Medicine, lists recruiting trials that you can search by condition, medication, or location. The Alzheimer's Association maintains a trial matching service called TrialMatch that connects participants with appropriate studies. Your parent's neurologist or cognitive disorder specialist likely has relationships with researchers conducting local trials. University medical centers often run memory disorder clinics and dementia research programs.

Be careful about trials that approach you through heavy advertising. Check who is running the study. A well-known academic medical center or reputable research hospital is a different proposition than an unfamiliar organization. Make sure the consent process seems thorough and honest.

Making the Decision

This comes down to balancing hope with realism and respecting your parent's autonomy.

Hope matters. If your parent feels hopeful about a trial and wants to participate, that is psychologically meaningful. The belief that you are doing something, that you are fighting back, carries real value. But hope needs to be grounded in reality. Your parent needs to understand the realistic chances.

Realism matters equally. Your parent is not likely to get a cure or a dramatic improvement. They might get modest slowing of decline. They might get nothing. They might get side effects. The participation will require time and effort, and the burden is real.

Some families decide participation makes sense because their parent's condition is early enough, the time commitment is manageable, the side effect risk seems acceptable, and the hope of contributing to science feels right. Other families decide the burden is too heavy, the realistic chances too small, or their parent's condition too advanced, and they choose to focus on quality of life and currently available treatments instead.

Both decisions are reasonable. Both can be right for different families and different situations. What matters is making the decision carefully, with understanding of the real situation, and with your parent's preferences at the center.

You are not failing your parent by choosing not to pursue a trial. You are not being reckless by choosing to pursue one. You are making the best decision you can with the information you have, and that is all anyone can do.

Frequently Asked Questions

Will my parent definitely get the experimental medication in a clinical trial?
Not necessarily. Many trials are randomized and placebo-controlled, meaning your parent could receive either the experimental treatment or a placebo. In double-blind trials, neither the participant nor the research team knows which one they are receiving. Some trials are open-label, where everyone gets the real medication.

Does participating in a clinical trial cost money?
The trial itself typically covers the cost of the experimental treatment and study-related procedures. However, standard medical care, travel to the research site, and time away from other responsibilities are not usually covered. Ask the research team about all potential out-of-pocket costs before enrolling.

Can my parent leave a clinical trial once they have enrolled?
Yes. Participation is voluntary and your parent can withdraw at any time for any reason. The research team should explain this during the informed consent process. Leaving a trial does not affect their right to receive standard medical care.

What if my parent can no longer make decisions about the trial as their condition progresses?
This depends on the trial's protocol and applicable state laws. Most trials require informed consent, and if your parent loses the capacity to consent, a legally authorized representative (often the person with healthcare power of attorney) may be able to make decisions on their behalf. Discuss this with the research team before enrollment.

How do I know if a clinical trial is legitimate and safe?
Look for trials registered on ClinicalTrials.gov, run by established academic medical centers or reputable research hospitals, and approved by an Institutional Review Board (IRB). The Alzheimer's Association TrialMatch service screens for legitimate studies. Ask the research team about their safety monitoring procedures and what happens if serious side effects occur.